North America Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End Users)
The North America drug delivery market is expected to grow from US$ 9,74,639.53 million in 2023 to US$ 14,29,417.79 million by 2028. It is estimated to register a CAGR of 8.0% from 2023 to 2028.
Rising Incidence of Chronic Diseases Fuel North America Drug Delivery Market
According to the Centers for Disease Control and Prevention (CDC), ~6 in 10 people in the US suffered from at least one chronic disease, while ~4 in 10 people had two or more chronic diseases as of 2019. Patients suffering from chronic medical conditions deteriorate with time, resulting in an enormous burden on patients' families and society. According to the projections of the American Cancer Society (ACS), the US is likely to record ~1,958,310 new cancer cases and 609,820 deaths in 2023. Diabetes is a life-threatening chronic disease with no specialized cure. All types of diabetes can lead to various complications in different body parts and increase the risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are the major complications associated with this disease. Cases of diabetes have been increasing significantly across the globe.
The increased prevalence of chronic diseases has promoted more intensive research and development (R&D) in drug delivery systems in the past few decades. The therapeutic efficacy of drugs used to treat chronic disease can be improved with optimal drug delivery systems, such as nanoparticles (e.g., ceramic, polymeric, and metallic), micelles, liposomes, and dendrimers. Administration of a drug with a drug delivery system can also help reduce systemic side effects of drugs. Various drug delivery vehicles have been introduced for a targeted and controlled delivery of therapeutics against a wide range of chronic diseases, such as diabetes, cancer, atherosclerosis, myocardial ischemia, asthma, pulmonary tuberculosis, Parkinson's, and Alzheimer's. An appropriate drug delivery system enhances the therapeutic efficacy of any drug by ensuring high drug bioavailability for a long duration. Targeted drug delivery systems (TDDS) release drugs in a controlled manner at a preselected site in a subject’s body. Nanotechnology-based delivery systems are making a significant impact on cancer treatment, and polymers play a key role in the development of these nanoparticulate carriers. In addition to the versatility of the administration route, a few of the noteworthy technological advantages of nanotherapeutic drug delivery systems (NDDS) are prolonged half-life, improved biodistribution, increased drug circulation time, controlled and sustained drug release, and elevated intercellular drug concentration.
Given the chronic nature of these conditions, patients with chronic diseases rely on continuous drug treatment, which is associated with an ongoing risk of side effects. Developing appropriate delivery systems for targeted drugs can promote the accumulation of targeted medicines in pathogenic lesions, reduce systemic side effects, and improve patient outcomes. Thus, the increasing incidences of chronic and lifestyle diseases bolster the growth of the North America drug delivery systems market.
North America Drug Delivery Market Overview
North America is the largest market for drug delivery, with the US holding the largest market share, followed by Canada. The market growth in North America is characterized by increased demand for rare disease medications from biopharmaceutical and biotechnology companies, the presence of key market players, and extensive R&D conducted by various academic and research institutes. In addition, extensive research in pharmaceutical and biotechnology companies is expected to support the growth of the drug delivery market in North America during the forecast period.
North America Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)
The North America drug delivery market is segmented on the basis of route of administration, distribution channel, end user, and country.
Based on route of administration, the North America drug delivery market is segmented into injectable drug delivery, oral drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. The injectable drug delivery segment held the largest share of the North America drug delivery market in 2023.
Based on distribution channel, the North America drug delivery market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the North America drug delivery market in 2023.
Based on end user, the North America drug delivery market is segmented into hospitals and clinics, home care settings, and other end users. The hospitals and clinics segment held the largest share of the North America drug delivery market in 2023.
Based on country, the North America drug delivery market is segmented into the US, Canada, and Mexico. The US dominated the share of the North America drug delivery market in 2023.
Bausch Health Companies Inc, Baxter International Inc., Becton Dickinson and Co, Boehringer Ingelheim International GmbH, Boston Scientific Corp, Gerresheimer AG, GlaxoSmithKline Plc, Johnson & Johnson, Kindeva Drug Delivery LP, Novartis AG, Novo Nordisk AS, Pfizer Inc, and Sever Pharma Solutions are the leading companies operating in the North America drug delivery market.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Drug Delivery Market – by Route of Administration
1.3.2 North America Drug Delivery Market – by Distribution Channel
1.3.3 North America Drug Delivery Market – by End User
1.3.4 North America Drug Delivery Market – by Country
2. North America Drug Delivery Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Drug Delivery Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert’s Opinion
5. North America Drug Delivery Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Chronic Diseases
5.1.2 Growing Demand for Noninvasive Drug Delivery Systems
5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
5.2 Key Market Restraints
5.2.1 High Cost Associated with Development of Drugs and Delivery Systems
5.2.2 Product Recalls in Drug Delivery Systems
5.3 Key Market Opportunities
5.3.1 Focus on Improving Patient Compliance
5.4 Future Trends
5.4.1 Strategic Developments and Product Launches
5.5 Impact analysis
6. Drug Delivery Market – North America Analysis
6.1 North America Drug Delivery Market Revenue Forecast and Analysis
7. North America Drug Delivery Market – Revenue and Forecast to 2028 – By Route of Administration
7.1 Overview
7.2 North America Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
7.3 Injectable Drug Delivery
7.3.1 Overview
7.3.2 Injectable Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Conventional Injection Devices
7.3.2.1.1 Overview
7.3.2.1.2 Conventional Injection Devices: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Advanced Devices
7.3.2.2.1 Overview
7.3.2.2.2 Advanced Devices: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Oral Drug Delivery
7.4.1 Overview
7.4.2 Oral Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.1 Solid Oral Drugs
7.4.2.1.1 Overview
7.4.2.1.2 Solid Oral Drugs: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.2 Liquid Oral Drugs
7.4.2.2.1 Overview
7.4.2.2.2 Liquid Oral Drugs: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.3 Semi-solid Oral Drugs
7.4.2.3.1 Overview
7.4.2.3.2 Semi-solid Oral Drugs: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Topical Drug Delivery
7.5.1 Overview
7.5.2 Topical Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.1 Semi-solid Topical Drug Delivery
7.5.2.1.1 Overview
7.5.2.1.2 Semi-solid Topical Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.2 Liquid Topical Drug Delivery Formulations
7.5.2.2.1 Overview
7.5.2.2.2 Liquid Topical Drug Delivery Formulations: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.3 Solid Topical Drug Delivery Formulations
7.5.2.3.1 Overview
7.5.2.3.2 Solid Topical Drug Delivery Formulations: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.4 Transdermal
7.5.2.4.1 Overview
7.5.2.4.2 Transdermal Patches: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Transmucosal Drug Delivery
7.6.1 Overview
7.6.2 Transmucosal Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.1 Pulmonary and Nasal Drug Delivery
7.6.2.1.1 Overview
7.6.2.1.2 Pulmonary and Nasal Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.2 Buccal and Sublingual Drug Delivery
7.6.2.2.1 Overview
7.6.2.2.2 Buccal and Sublingual Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.3 Rectal Transmucosal Drug Delivery
7.6.2.3.1 Overview
7.6.2.3.2 Rectal Transmucosal Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.6.2.4 Vaginal Transmucosal Drug Delivery
7.6.2.4.1 Overview
7.6.2.4.2 Vaginal Transmucosal Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Implantable Drug Delivery
7.7.1 Overview
7.7.2 Implantable Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Ocular Drug Delivery
7.8.1 Overview
7.8.2 Ocular Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.1 Eye Drops and Sprays
7.8.2.1.1 Overview
7.8.2.1.2 Eye Drops and Sprays: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.2 Gels and Ointments
7.8.2.2.1 Overview
7.8.2.2.2 Gels and Ointments: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.3 Ocular Inserts and Punctal Plugs
7.8.2.3.1 Overview
7.8.2.3.2 Ocular Inserts and Punctal Plugs: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
7.8.2.4 Therapeutic Contact Lens
7.8.2.4.1 Overview
7.8.2.4.2 Therapeutic Contact Lens: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Drug Delivery Market – Revenue and Forecast to 2028 – By Distribution Channel
8.1 Overview
8.2 North America Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: North America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Retail Pharmacies
8.4.1 Overview
8.4.2 Retail Pharmacies: North America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Online Pharmacies
8.5.1 Overview
8.5.2 Online Pharmacies: North America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Drug Delivery Market – Revenue and Forecast to 2028 – By End User
9.1 Overview
9.2 North America Drug Delivery Systems Market Revenue Share, by End User (2022and 2028)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: North America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Home Care Settings
9.4.1 Overview
9.4.2 Home Care Settings: North America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Other End User
9.5.1 Overview
9.5.2 Other End User: North America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Drug Delivery Market – Revenue and Forecast to 2028 – Country Analysis
10.1 Overview
10.1.1 North America Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
10.1.1.1 US: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 US: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 US: North America Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.1.3.1 US: North America Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.3.2 US: North America Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.3.3 US: North America Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.3.4 US: North America Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.3.5 US: North America Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.1.4 US: North America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.1.5 US: North America Drug Delivery Market, by End User 2020-2028 (US$ Million)
10.1.1.2 Canada: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Canada: North America Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.2.3.1 Canada: North America Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.3.2 Canada: North America Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.3.3 Canada: North America Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.3.4 Canada: North America Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.3.5 Canada: North America Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.2.4 Canada: North America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.2.5 Canada: North America Drug Delivery Market, by End User 2020-2028 (US$ Million)
10.1.1.3 Mexico: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Mexico: North America Drug Delivery Market, by Route of Administration, 2020–2028 (US$ Million)
10.1.1.3.3.1 Mexico: North America Drug Delivery Market, by Injectable Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.3.2 Mexico: North America Drug Delivery Market, by Oral Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.3.3 Mexico: North America Drug Delivery Market, by Topical Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.3.4 Mexico: North America Drug Delivery Market, by Transmucosal Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.3.5 Mexico: North America Drug Delivery Market, by Ocular Drug Delivery, 2020–2028 (US$ Million)
10.1.1.3.4 Mexico: North America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
10.1.1.3.5 Mexico: North America Drug Delivery Market, by End User 2020-2028 (US$ Million)
11. North America Drug Delivery Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies in North America Drug Delivery Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Becton Dickinson and Co
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Novo Nordisk AS
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boston Scientific Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Baxter International Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Gerresheimer AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Kindeva Drug Delivery LP
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 GlaxoSmithKline Plc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.5.1 Key Developments
12.8 Bausch Health Companies Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Boehringer Ingelheim International GmbH
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Novartis AG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Sever Pharma Solutions
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Johnson & Johnson
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 Pfizer Inc
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. US: North America Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 2. US: North America Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 3. US: North America Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 4. US: North America Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 5. US: North America Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 6. US: North America Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 7. US: North America Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 8. US: North America Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada: North America Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada: North America Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada: North America Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada: North America Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada: North America Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada: North America Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada: North America Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 16. Canada: North America Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico: North America Drug Delivery Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico: North America Drug Delivery Market, by Injectable Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico: North America Drug Delivery Market, by Oral Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico: North America Drug Delivery Market, by Topical Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 21. Mexico: North America Drug Delivery Market, by Transmucosal Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 22. Mexico: North America Drug Delivery Market, by Ocular Drug Delivery – Revenue and Forecast to 2028 (US$ Million)
Table 23. Mexico: North America Drug Delivery Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
Table 24. Mexico: North America Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. Recent Organic Growth Strategies in North America Drug Delivery Market
Table 26. Recent Inorganic Growth Strategies in the North America Drug Delivery Market
Table 27. Glossary of Terms, North America Drug delivery market
LIST OF FIGURES
Figure 1. North America Drug Delivery Market Segmentation
Figure 2. North America Drug Delivery Market by Country
Figure 3. North America Drug Delivery Market Overview
Figure 4. Injectable Drug Delivery to Hold the Largest Share of Route of Administration Segment in North America Drug Delivery Market
Figure 5. The US Expected to Show Remarkable Growth During Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. North America Drug Delivery Market Impact Analysis of Drivers and Restraints
Figure 9. North America Drug Delivery Market – Revenue Forecast and Analysis – 2020–2028
Figure 10. North America Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
Figure 11. Injectable Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Conventional Injection Devices: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Advanced Devices: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Oral Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Solid Oral Drugs: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Liquid Oral Drugs: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Semi-solid Oral Drugs: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Topical Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Semi-solid Topical Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Liquid Topical Drug Delivery Formulations: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Solid Topical Drug Delivery Formulations: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Transdermal Patches: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Transmucosal Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Pulmonary Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Buccal and Sublingual Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Rectal Transmucosal Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Vaginal Transmucosal Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Implantable Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Ocular Drug Delivery: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Eye Drops and Sprays: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Gels and Ointments: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Ocular Inserts and Punctal Plugs: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Therapeutic Contact Lens: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. North America Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
Figure 35. Hospital Pharmacies: North America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Retail Pharmacies: North America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Online Pharmacies: North America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. North America Drug Delivery Systems Market Revenue Share, by End User (2022 and 2028)
Figure 39. Hospitals and Clinics: North America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Home Care Settings: North America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Other End User: North America Drug Delivery Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. North America Drug Delivery Systems Market, by Key Country – Revenue (2022) (US$ Million)
Figure 43. North America Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
Figure 44. US: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Canada: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Mexico: North America Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Growth Strategies in North America Drug Delivery Market
- Bausch Health Companies Inc
- Baxter International Inc
- Becton Dickinson and Co
- Boehringer Ingelheim International GmbH
- Boston Scientific Corp
- Gerresheimer AG
- GlaxoSmithKline Plc
- Johnson & Johnson
- Kindeva Drug Delivery LP
- Novartis AG
- Novo Nordisk AS
- Pfizer Inc
- Sever Pharma Solutions
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America drug delivery market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in North America drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.